Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2026-01-25 @ 9:37 PM
Study NCT ID:
NCT03570450
Status:
RECRUITING
Last Update Posted:
2023-07-27
First Post:
2018-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1
Sponsor:
University Hospital, Grenoble
Organization:
Study Overview
Official Title:
Regenerative Stem Cell Therapy for Stroke in Europe 1
Status:
RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke recovery and patients quality of life.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: